Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors

NEXT STORY
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
PREV STORY
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Worldwide Veterinary Orthopedics Industry to 2027 – Advancement in Quality Associated With Petcare Digital Imaging Systems Presents Opportunities

author_avatar
NASDAQ Market News

BioXcel Therapeutics Announces Primary and Secondary Endpoints Met in Two Pivotal Phase 3 Trials of BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder

author_avatar
NASDAQ Market News

GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and the 81st Scientific Sessions of the American Diabetes Association

author_avatar
NASDAQ Market News